Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Nigel Dally maintains an Overweight rating on MetLife (NYSE:MET) and raises the price target from $80 to $82.
April 15, 2024 | 4:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley maintains an Overweight rating on MetLife and raises the price target from $80 to $82.
The upgrade in price target by a reputable analyst like Nigel Dally from Morgan Stanley suggests a positive outlook on MetLife's stock, likely due to strong fundamentals or expected performance improvements. This can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100